Spcification
| Common Name | Detomidine | ||
|---|---|---|---|
| CAS Number | 76631-46-4 | Molecular Weight | 186.25300 |
| Density | 1.077 g/cm3 | Boiling Point | 386.5ºC at 760 mmHg |
| Molecular Formula | C12H14N2 | Melting Point | 160ºC |
| MSDS | N/A | Flash Point | 200.6ºC |
Detomidine produce dose-dependent sedative and analgesic effects, is a nonnarcotic, synthetic α2-adrenergic agonistTarget: α2-adrenergic agonistDetomidine is an imidazole derivative and α2-adrenergic agonist, used as a large animal sedative, primarily used in horses. It is usually available as the salt detomidine hydrochloride. It is a prescription medication available to veterinarians sold under the trade name Dormosedan. Currently, detomidine is only licenced for use in horses.Detomidine is a sedative with analgesic properties. α2-adrenergic agonists produce dose-dependent sedative and analgesic effects, mediatated by activation of α2 catecholamine receptors, thus inducing a negative feedback response, reducing production of excitatory neurotransmitters. Due to inhibition of the sympathetic nervous system, detomidine also has cardiac and respiratory effects and an antidiuretic action.
Spcification
| Common Name | Detomidine | ||
|---|---|---|---|
| CAS Number | 76631-46-4 | Molecular Weight | 186.25300 |
| Density | 1.077 g/cm3 | Boiling Point | 386.5ºC at 760 mmHg |
| Molecular Formula | C12H14N2 | Melting Point | 160ºC |
| MSDS | N/A | Flash Point | 200.6ºC |
Detomidine produce dose-dependent sedative and analgesic effects, is a nonnarcotic, synthetic α2-adrenergic agonistTarget: α2-adrenergic agonistDetomidine is an imidazole derivative and α2-adrenergic agonist, used as a large animal sedative, primarily used in horses. It is usually available as the salt detomidine hydrochloride. It is a prescription medication available to veterinarians sold under the trade name Dormosedan. Currently, detomidine is only licenced for use in horses.Detomidine is a sedative with analgesic properties. α2-adrenergic agonists produce dose-dependent sedative and analgesic effects, mediatated by activation of α2 catecholamine receptors, thus inducing a negative feedback response, reducing production of excitatory neurotransmitters. Due to inhibition of the sympathetic nervous system, detomidine also has cardiac and respiratory effects and an antidiuretic action.
